161 related articles for article (PubMed ID: 37265428)
21. The tumor suppressor p53 is a negative regulator of the carcinoma-associated transcription factor FOXQ1.
Pizzolato G; Moparthi L; Pagella P; Cantù C; D'Arcy P; Koch S
J Biol Chem; 2024 Apr; 300(4):107126. PubMed ID: 38432629
[TBL] [Abstract][Full Text] [Related]
22. PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.
Meng F; Speyer CL; Zhang B; Zhao Y; Chen W; Gorski DH; Miller FR; Wu G
Cancer Res; 2015 Feb; 75(3):584-93. PubMed ID: 25502837
[TBL] [Abstract][Full Text] [Related]
23. FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis.
Mitchell AV; Wu L; James Block C; Zhang M; Hackett J; Craig DB; Chen W; Zhao Y; Zhang B; Dang Y; Zhang X; Zhang S; Wang C; Gibson H; Pile LA; Kidder B; Matherly L; Yang Z; Dou Y; Wu G
Nat Commun; 2022 Nov; 13(1):6548. PubMed ID: 36319643
[TBL] [Abstract][Full Text] [Related]
24. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
25. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.
Liu Q; Cao Y; Wei X; Dong H; Cui M; Guan S; Liu B; Wang X; Xing P
Cell Death Dis; 2023 Dec; 14(12):803. PubMed ID: 38062011
[TBL] [Abstract][Full Text] [Related]
26. MiR-4319 induced an inhibition of epithelial-mesenchymal transition and prevented cancer stemness of HCC through targeting FOXQ1.
Han S; Shi Y; Sun L; Liu Z; Song T; Liu Q
Int J Biol Sci; 2019; 15(13):2936-2947. PubMed ID: 31853229
[TBL] [Abstract][Full Text] [Related]
27. The oncogenic transcription factor FOXQ1 is a differential regulator of Wnt target genes.
Pizzolato G; Moparthi L; Söderholm S; Cantù C; Koch S
J Cell Sci; 2022 Oct; 135(19):. PubMed ID: 36124643
[TBL] [Abstract][Full Text] [Related]
28. FOXQ1 promotes esophageal cancer proliferation and metastasis by negatively modulating CDH1.
Pei Y; Wang P; Liu H; He F; Ming L
Biomed Pharmacother; 2015 Aug; 74():89-94. PubMed ID: 26349968
[TBL] [Abstract][Full Text] [Related]
29. Research progress on the regulation of tumor initiation and development by the forkhead box Q1 gene.
Tang H; Zhang J; Guo Q
J Cancer Res Ther; 2018 Jan; 14(1):6-11. PubMed ID: 29516951
[TBL] [Abstract][Full Text] [Related]
30. Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer.
Bortnik S; Tessier-Cloutier B; Leung S; Xu J; Asleh K; Burugu S; Magrill J; Greening K; Derakhshan F; Yip S; Ng T; Gelmon KA; Nielsen TO; Gorski SM
Breast Cancer Res Treat; 2020 Oct; 183(3):525-547. PubMed ID: 32685993
[TBL] [Abstract][Full Text] [Related]
31. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway.
Zhang JJ; Cao CX; Wan LL; Zhang W; Liu ZJ; Wang JL; Guo Q; Tang H
World J Gastroenterol; 2022 May; 28(17):1781-1797. PubMed ID: 35633908
[TBL] [Abstract][Full Text] [Related]
32. FOXQ1-mediated SIRT1 upregulation enhances stemness and radio-resistance of colorectal cancer cells and restores intestinal microbiota function by promoting β-catenin nuclear translocation.
Yang M; Liu Q; Dai M; Peng R; Li X; Zuo W; Gou J; Zhou F; Yu S; Liu H; Huang M
J Exp Clin Cancer Res; 2022 Feb; 41(1):70. PubMed ID: 35183223
[TBL] [Abstract][Full Text] [Related]
33. Forkhead box Q1: A key player in the pathogenesis of tumors (Review).
Li Y; Zhang Y; Yao Z; Li S; Yin Z; Xu M
Int J Oncol; 2016 Jul; 49(1):51-8. PubMed ID: 27176124
[TBL] [Abstract][Full Text] [Related]
34. FOXQ1, a novel target of the Wnt pathway and a new marker for activation of Wnt signaling in solid tumors.
Christensen J; Bentz S; Sengstag T; Shastri VP; Anderle P
PLoS One; 2013; 8(3):e60051. PubMed ID: 23555880
[TBL] [Abstract][Full Text] [Related]
35. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
36. FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT.
Feng J; Zhang X; Zhu H; Wang X; Ni S; Huang J
PLoS One; 2012; 7(6):e39937. PubMed ID: 22761930
[TBL] [Abstract][Full Text] [Related]
37. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
38. FoxQ1 promotes glioma cells proliferation and migration by regulating NRXN3 expression.
Sun HT; Cheng SX; Tu Y; Li XH; Zhang S
PLoS One; 2013; 8(1):e55693. PubMed ID: 23383267
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of FOXQ1 enhances anti-senescence and migration effects of human umbilical cord mesenchymal stem cells in vitro and in vivo.
Zhang T; Wang P; Liu Y; Zhou J; Shi Z; Cheng K; Huang T; Wang X; Yang GL; Yang B; Ma S; Guan F
Cell Tissue Res; 2018 Aug; 373(2):379-393. PubMed ID: 29500491
[TBL] [Abstract][Full Text] [Related]
40. Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell.
Qin J; Xu Y; Li X; Wu Y; Zhou J; Wang G; Chen L
Exp Mol Pathol; 2014 Feb; 96(1):1-8. PubMed ID: 24211718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
